<DOC>
	<DOCNO>NCT01537380</DOCNO>
	<brief_summary>With 6.5 million obese record France 2009 , obesity major public health : chronic disease associate many respiratory , cardiac , metabolic , musculoskeletal complication . The risk mortality morbidity directly proportional importance overweight medical treatment alone moderately effective weight loss . Bariatric surgery treatment proven efficacy patient body mass index 40 kg/m2 . As surgery , risk surgical site infection ( SSI ) . The SSI third common nosocomial infection urinary tract infection airway . The fight ISO require administration antibiotic prophylaxis act main bacteria find bariatric surgery . There several study literature interested dose cefazolin bariatric surgery . However , publish pharmacokinetic study define optimal dose obtain tissue plasmatic concentration cefazolin high minimum inhibitory concentration main germ encounter surgery . Only empirical recommendation publish , include SFAR National Institute Health 2010 . This study aim determine whether dose 4 gram cefazolin achieve goal concentration estimate injection time preoperative ideal adequate tissue concentration time incision .</brief_summary>
	<brief_title>Tissue Plasma Pharmacokinetics Cefazolin Antibiotic Prophylaxis Bariatric Surgery</brief_title>
	<detailed_description />
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Cefazolin</mesh_term>
	<criteria>Male female , age &gt; 18 year . BMI ≥ 40 ≤ 65 kg/m2 . The patient give informed consent writing . Age le 18 year 70 year . Major Trust . Pregnancy . Moderate severe renal insufficiency clearance creatinine clearance &lt; 60 ml / min Hypersensitivity cephalosporins betalactams .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>